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CURRENT DEBATE
Reframing NCDs? An analysis of current debates
Kafui Adjaye-Gbewonyo and Megan Vaughan
Institute of Advanced Studies, University College London, London, UK
ABSTRACT
There have been many debates in recent years as to whether the communicable disease
versus non-communicable disease (NCD) division is a meaningful one in disease classification.
Several critiques have been raised about the framing of NCDs, regarding not only the
prominent role that infections play in the aetiology of NCDs, but also the communicability
of many social determinants of NCDs and the individualistic, ‘lifestyle’ framing of NCDs that
tends to focus on health behaviours to the neglect of socio-political, environmental, and
structural determinants of health. In this paper, we give a historical overview of the usage of
the NCD terminology and analyse some of the recent debates regarding the naming and
framing of NCDs. We argue that a lack of reflection on the assumptions underlying the
naming and framing of NCDs may lead to the collection of insufficient epidemiological data,
the development of inappropriate interventions and the provision of inadequate care. Work
in social epidemiology, health promotion, medical anthropology, demography, and other
fields may provide insights into the ways in which efforts targeting NCDs may be reframed to
improve impact and efficacy. In addition, concepts such as multimorbidity and syndemics,
frameworks such as ecosocial theory and approaches based in the social sciences may
provide a way forward in the conceptualization of disease.
ARTICLE HISTORY
Received 27 February 2019
Accepted 3 July 2019
RESPONSIBLE EDITOR
Stig Wall, Umeå University,
Sweden
KEYWORDS
Non-communicable
diseases; social determinants
of health; epidemiology;
health transitions
Background
‘Non-communicable diseases (NCDs)’ seems to have
become a catchphrase in global health. While its defini-
tion is not universally agreed upon, according the
Medical Subject Headings (MeSH) definition for
NCDs, which was just introduced in 2018, NCDs are
‘Diseases of long duration and generally slow
progression’. The MeSH definition goes on to state
that, ‘The four main types of noncommunicable dis-
eases are cardiovascular diseases (e.g. heart attacks and
stroke), cancer, chronic respiratory diseases (e.g.
chronic obstructive pulmonary disease and asthma)
and diabetes mellitus’ [1]. This paper seeks to question
and problematize the concept of NCDs by reflecting on
the assumptions behind this category and how they
might affect research and practice. The goal of this
paper is not necessarily to argue for abandoning the
phrase ‘NCDs’ or to suggest an alternative, but rather to
analyse some of the recent debates around the framing
of NCDs and the underlying issues these debates point
to. Our main argument is that the public health com-
munity may need to be more reflexive and critical of the
sometimes inadequate and artificial divisions used in
classifying diseases and how these divisions may limit
the ways in which we research and intervene in health.
Concepts such as multimorbidity and syndemics, fra-
meworks such as ecosocial theory and social-science-
based approaches may provide a more useful way to
understand the epidemiologic challenges of our time.
But first, it may be useful to look briefly at the history of
the term’s usage in the scientific literature.
NCDs: usage over time
The concept of what we call NCDs largely developed
from the notion of ‘chronic disease’, and the two phrases
often continue to be used interchangeably. The phrase
‘chronic disease’ has a longer history of common use,
withWeisz noting that it dates back to the Greco Roman
period [2]. Such diseases, whether infectious or not, were
historically viewed as incurable. However, it is in the
twentieth century that the concepts of chronic disease
and chronic illness began to acquire the meanings and
significance to which we assign them today, often con-
noting non-infectious conditions that typically require
chronic care and are frequently, though not exclusively,
associated with aging. In the 1920s, chronic diseases
became a regular category in Index Medicus, with
‘chronic illness’ being added in 1947 [2,3]. In 1935, the
U.S. undertook its first National Health Survey of
Chronic Illness and Disability, which later became the
National Health Interview Survey. Weisz notes that the
concept of chronic disease was initially largely an
American concern until the 1960s when it began to be
adopted by other countries [2]. In the post-World-War-II
era, British epidemiologists such as Bradford Hill, Doll
andMcKeown also advanced the study of chronic disease
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with their research on smoking, cardiovascular disease
and cancer [4]. The study and control of chronic disease
in the last century greatly influenced the fields of epide-
miology and public health, simultaneously advancing the
more individualistic biomedical and lifestyle models of
disease [2,5–7]. For example, it was from the
Framingham Heart Study, that the phrase ‘risk factor’
was coined in 1961 [6].
Thus, a distinction was made in terms of the duration
of disease where many infectious conditions were viewed
as being acute, resulting in either death or recovery, while
many non-infectious diseases were seen as incurable and
chronic [2]. However, this distinction has not always
been so clear cut as many have noted [2,8], and it can
becomeproblematic in its focus on biomedical constructs
without recognition of social factors that may impact the
curability and chronicity of disease, such as access to
care [9].
In recent years, the phrase ‘NCDs’ has often been
applied, with a more global outlook. In the 1970s,
NCDs became part of the global health agenda with
efforts of the World Health Organisation (WHO), such
as through their Noncommunicable Disease Division,
and in the 1980s this focus expanded to low- andmiddle-
income countries (LMICs) with the WHO’s
INTERHEALTHprogramme [2,5]. In addition, the land-
mark Global Burden of Disease (GBD) Studies, initially
published for the World Bank in 1993 and subsequently
conducted with the participation of the WHO, have
helped to familiarise stakeholders with the term ‘NCDs’
and with the significance of their disease burden. The
GBD studies provide global estimates of the burden of
various diseases and risk factors and classify diseases and
conditions into three broad categories at Level 1. These
are: (1) Communicable, maternal, perinatal/neonatal and
nutritional conditions; (2) non-communicable diseases;
and (3) injuries. These broad categories are further bro-
ken down at Levels 2 and 3 following the International
Classification of Diseases [10–12]. The significance of
these studies to global health and policy has arguably
helped to solidify a standard classification of diseases.
Moreover, recognition of the fact that many infectious
diseases, like tuberculosis, are also chronic, and that with
improved treatment, diseases such as AIDS have also
become chronic, has spurred wider use of the term
‘NCDs’ to further distinguish these ‘non-infectious’ con-
ditions from other diseases that are also chronic in nature
but viewed as infectious.
To illustrate how the use of the phrase ‘NCDs’ has
evolved over time, we conducted a search for the phrase
‘NCDs’ in PubMed using the search terms in Box 1
below. The search produced over 8000 results, the earliest
of which is a Portuguese-language paper from Brazil
published in 1961 by D. Wilson and entitled, ‘The con-
siderable increase of non-communicable diseases as
causes of death in the city of Sao Paulo from 1900 to
1960’ [13].
This was followed by several papers in Russian
from the late 1960s on animal non-communicable
diseases [14–17]. The next references relating to
human disease were a 1972 article in German on
‘Activities of the World Health Organization in the
field of non-communicable diseases’ [18], followed by
a 1977 Spanish-language paper from Mexico,
‘Control of noncommunicable diseases in the primary
level of health care’ [19].
Thus, many of the early references to NCDs that are
indexed in PubMed come from non-English-language
uses of the terminology, and it is not until mid-1977
that an English-language paper from the Canadian
Journal of Public Health is documented in PubMed
using the phrase in its title [20]. Publications docu-
mented in PubMed using the phrase NCDs have stea-
dily increased over time, taking off particularly in
the second decade of the 2000s (Figure 1).
Given that PubMed may not contain a complete list-
ing of scholarly publications on NCDs, we conducted
similar searches in Google Scholar and Web of Science
for comparison. In Google Scholar, a search of the terms
‘non-communicable disease(s)’ or ‘noncommunicable
disease(s)’ retrieves an earlier publication in the Journal
of Chronic Diseases in its initial year of publication in
1955 [2,21]. This paper additionally cites the 1954 article,
‘Epidemiology inNoncommunicableDisease,’byGilliam
[22]. Web of Science searches produce largely similar
results beginningwith the 1954 paper byGilliam followed
by citations from the early 1970s, which include reviews
for the books Communicable and Noncommunicable
Diseases by Jones, Shainberg and Byer and Epidemiology
of Non-Communicable Disease by Acheson. Thus, it is
evident from these three searches that certainly by the
mid-twentieth century, the phrase ‘NCDs’ had begun to
be used in academic circles and that its usage has grown
in recent years.
The dramatic increase in publications on NCDs illu-
strated in Figure 1 largely mirrors events occurring in the
global health arena over the past decade. In 2008, the
WHO’s annualWorldHealth Statistics report highlighted
the global shift from infectious to non-communicable
diseases [23], and the organisation released its
2008–2013 Action Plan for the Global Strategy for the
Prevention and Control of Noncommunicable Diseases
[24]. In 2011, theUnitedNations (UN) held its firstHigh-
Box 1. Pubmed search terms for NCDs.
“noncommunicable diseases“[MeSH Terms] OR
(“noncommunicable“[All Fields] AND “diseases”[All Fields]) OR
”noncommunicable diseases”[All Fields] OR ”non communicable
diseases”[All Fields]
(Search conducted 12 November 2018)
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Level Meeting on NCDs with subsequent meetings in
July 2014 and most recently in September 2018.
Framing NCDs
The 2008 WHO report, the UN High-Level Meetings
on NCDs and the activism around these events from
organizations such as the NCD Alliance [25], helped to
put NCDs on the global health map, increasing recog-
nition of the term and the problem. The drive to
increase global action on NCDs can in some ways be
seen as a reaction to the intense focus on the commu-
nicable, maternal, neonatal and nutritional group of
diseases in the Millennium Development Goals
(MDGs) which helped to shape the global health
agenda in the early 2000s [26]. For example, some of
the major global health funders of the early twenty-first
century – the Global Fund to Fight AIDS, Tuberculosis
& Malaria; the U.S. President’s Emergency Plan for
AIDS Relief; the Bill & Melinda Gates Foundation;
UNAIDS; Clinton Health Access Initiative, the Global
Alliance for Vaccines and Immunization – were largely
motivated in response to the health-related MDGs and
other global commitments which focused on under-
nutrition, maternal and child health, malaria and AIDS
[27,28]. For those working in NCD areas, this focus
was seen to neglect NCDs, which were known to be
major global killers and also on the rise. Thus, the
advocacy work and research to recognise the NCD
‘epidemic’ helped to ensure that NCDs were included
in the Sustainable Development Goals (SDGs) with
SDG 3, ‘Ensure healthy lives and promote well-being
for all at all ages,’ encompassing not just nutritional,
maternal, neonatal and infectious diseases but also
NCDs, injuries and neglected tropical diseases [26].
Nevertheless, the very act of emphasizing the distinc-
tion between NCDs and infectious and other diseases
in order to raise awareness, may also have contributed
to some of the controversies and complications that we
will discuss below.
The framing ofNCDs has historically been dominated
by several related frameworks. These are the biomedical
model and lifestyle frameworks and the theory of epide-
miological transition. The biomedical model, which
characterized epidemiology in the twentieth century,
centres on biological and physical causes and mechan-
isms of disease. It focuses on individuals and is reduc-
tionist in nature, viewing the whole as merely the sum of
its parts [6]. In the context of NCDs, this framing has put
an emphasis on risk factors, including genetic and bio-
logical risk factors such as age, race/ethnicity, sex, family
history, et cetera. The ‘lifestyle’ framing similarly puts
emphasis on individuals, with a focus on health beha-
viours which are often implicitly assumed to be lifestyle
‘choices’ [6]. When applied to NCDs, the ‘lifestyle’ fram-
ing has tended to focus on the ‘big four’ conditions
described in the MeSH definition of NCDs (cancer,
cardiovascular diseases, diabetes and chronic respiratory
diseases) and four major modifiable risk factors of
tobacco, alcohol, physical inactivity and unhealthy diets.
The theory of epidemiological transition has also
played a role in the framing of NCDs. First described
by Abdul Omran in 1971, the theory put forward
a model in which societies transition from having an
epidemiologic and mortality profile marked by under-
nutrition and infectious disease (age of pestilence and
famine), to a period in which such conditions decline,
and finally toward a stage dominated by chronic and
non-communicable diseases as life expectancies, eco-
nomic prosperity and industrialisation increase (age of
degenerative and man-made diseases) [29–31]. This has
been used to explain and predict trends of increasing
rates of NCDs and declines in infectious disease glob-
ally, particularly in LMICs. It has often also been inter-
preted to suggest that NCDs are associated with
affluence and economic well-being because they are
expected to become more prevalent as nations indus-
trialise and develop economically. Through all this,
a distinction has been made between infectious diseases
and NCDs as being separate across time and space.
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Figure 1. Pubmed indexed publications on NCDs by year.
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Reframing NCDs
The framing of NCDs and what is being overlooked
have been growing topics of concern, however. These
concerns have largely been motivated by desires to
increase attention to and resources for certain types of
NCDs or NCDs generally. Building on issues raised in
a 2011 conference on the endemic NCDs of the poor
[32], in 2015 physicians Gene Bukhman and Ana
Mocumbi launched a Lancet Commission on
Reframing NCDs and Injuries for the Poorest Billion
(Lancet NCDI Poverty Commission), whose goal was to
bring an equity lens to the NCD agenda by highlighting
the types of NCDs linked to poverty–conditions that are
often neglected by the framing of NCDs as ‘lifestyle’ or
behavioural diseases [33]. Bukhman and colleagues
argue that the NCDs that have been prevalent in some
of the poorest communities worldwide instead include
conditions such as rheumatic heart disease and Burkitt’s
Lymphoma – which have infectious and environmental
causes rather than behavioural causes – as well as con-
genital and genetic disorders and mental illness and
injuries. Indeed, the biomedical and lifestyle/behaviour
framing of NCDs has often pushed environmental and
structural determinants of health to the background
[33–35]. A recent article about global environmental
change and NCDs noted that not only have environ-
mental determinants of NCDs been overlooked in the
past by the WHO and others, but also that even the
recent debates on the framing of NCDs have continued
to ignore global environmental change [35]. It was only
last year that air pollution, for example, was added as
a risk factor to the WHO framework on NCDs [36].
Complementary efforts to re-examine notions of
epidemiological transition and NCDs from a historical
perspective have been underway with the ‘Chronic
Disease in Sub-Saharan Africa: A Critical History of
an ‘Epidemiological Transition’’ project led by historian
Megan Vaughan at University College London [37].
This project seeks to challenge the idea of transition
by examining local histories and conditions; it also seeks
to highlight the important interactions between infec-
tious diseases and NCDs, interactions that are often
overlooked when dividing these conditions into distinct
categories or assigning them to different points in time.
Public health specialists Abel and McQueen have
also critiqued the theoretical framing of NCDs [38].
They argue that while theories of NCDs are often not
made explicit, the epidemiological basis used to study
NCDs has implicitly led to a focus on individuals to
the exclusion of contextual factors; the social is essen-
tially only studied to the extent that it can be causally
linked to biological disease. The authors argue that
this framing has also led to a focus on risk, risk
factors and disease rather than on health and health
resources, making individuals and populations pas-
sive recipients of health-damaging exposures rather
than co-producers of health. In addition, they argue
that the framing of NCDs typically relies on reduc-
tionist one-way, linear causal thinking, often ignoring
complexity. The authors advocate instead for a social-
science-based and health-promotion-focused frame-
work for NCDs, a point that will be returned to later
in this article.
Recent debates on the NCD moniker
Along similar lines, there have also been a number of
recent debates as to whether the name ‘NCD’ itself is
even an effective or useful one. In the early- to mid-
2000s, one such debate appeared in the Journal of
Epidemiology and Community Health. Ackland and
colleagues called for returning to the phrase ‘chronic
disease’ in place of ‘NCD’, arguing that the societal
determinants of health behaviours are communic-
able – they are marketed, communicated and passed
down through families and communities along social
gradients – and thus should be treated as social
‘vectors’ and as the focus of interventions. The
authors hoped to place a sense of urgency and moti-
vate ‘upstream’ thinking on chronic disease and
added that the phrase ‘transmissible chronic disease’
could be used to emphasize these social determinants
[39,40]. Unwin and colleagues disagreed with their
proposal, however, noting that it confused
a classification based on causes (communicable and
non-communicable) with one based on effects (acute
versus chronic), overlooking the fact that many
chronic conditions were communicable and many
non-communicable conditions were acute [40].
This debate highlighted several themes that would
be returned to nearly a decade later in the 2010s. One
work that revisited such themes was the Global
Handbook on Noncommunicable Diseases and
Health Promotion [7]. In the introduction to the
volume, editor David McQueen lamented the ‘pro-
crustean’ nature of the NCD terminology which has
been a subject of debate in public health. The short-
comings of this terminology included the implied
non-infectious aetiology of NCDs, despite the fact
than many NCDs have infection-related aetiologies.
While most public health researchers and practi-
tioners do recognise the limitations of the NCD ter-
minology, he noted that it has become a globally
accepted term, in part because of its use by the
WHO [41].
In his 2014 book, Infections, Chronic Disease and
the Epidemiological Transition, demographer
Alexander Mercer proposed that when classifying
diseases, a combination of three dimensions be con-
sidered, while simultaneously allowing for potentially
unknown factors in these dimensions [8]. One
dimension is the cause of the disease (infectious
agent – known, possible or none); the second is the
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effect of the condition (acute or chronic); and the
third is communicability. Thus, diseases could be
viewed as acute and communicable with known
infectious causes (e.g. measles), chronic and commu-
nicable with known infectious causes (e.g. tuberculo-
sis), chronic with non-infectious aetiology and not
communicable (e.g. genetic disorders, though one
could in theory argue that genetic transmission is
a form of communicability), et cetera. This model
for classifying disease is perhaps more precise than
our current classification system though a bit more
cumbersome as well.
In late 2016, a discussion was started by Justin
Zaman in the ‘Non-Communicable Diseases’ online
community at GHDonline, a platform of medical and
health professionals that forms part of the Global
Health Delivery project [42]. He argued that far
from being ‘non-communicable’, NCDs were in fact
‘spreading’ from urban to rural areas with globaliza-
tion and ‘development’. In the responses that fol-
lowed, some agreed with Zaman, while others
commented that conditions such as hypertension
are also high in communities that have not yet
adopted dietary and lifestyle changes characteristic
of ‘economic development’. Yet other responses con-
tended that the NCD versus infectious disease dis-
tinction is relevant and is borne out by the fact that
one says that a person is ‘affected’ by an NCD and
not ‘infected’ by it, or that while infections such as
HPV can cause NCDs, the cancers themselves are not
infectious diseases.
In 2017, this debate was taken to the Lancet Global
Health by Luke Allen and Andrea Feigl after
a commentary by Lancet editor Richard Horton
lamented why the global health community has not
effectively responded to NCDs and suggested that
framing NCDs in terms of fear and security risks, in
the way that infectious diseases have been framed,
may help [43,44]. This lack of charisma for NCDs
compared to infectious diseases has also been high-
lighted by geographer Clare Herrick [45]. Allen &
Feigl responded to Horton’s commentary by arguing
that classifying NCDs in terms of what they are not
deprives them of the urgency needed to tackle the
epidemic and focuses on the individual-level rather
than societal-level drivers of these conditions. They
solicited suggestions from the Lancet readership as
well as the GHDonline community to re-name
NCDs. Several authors responded to their call with
commentaries in Lancet Global Health. Some of the
names that were put forward included, ‘lifelong dis-
eases’ and ‘biosocial and development diseases’,
among others [35].
Synthesizing the feedback they received, Allen and
Feigl eventually proposed the phrase ‘socially-
transmitted conditions (STCs)’ as an alternative to
‘NCDs’ in order to draw attention to the shared
commercial and social determinants of these condi-
tions [46]. However, in follow-up discussions,
Cavalin and Lescoat argued that this phrase may
inadvertently lead to the suggestion that infectious
diseases do not share some of these social determi-
nants [47]. Nevertheless, on the GHDonline commu-
nity, some feedback on this debate suggested that
worrying about the NCD name may be of little rele-
vance to communities and that energies should
instead be devoted to taking action to prevent
them [48].
However, the discussion about the framing and
naming of NCDs has not gone away. In a recent
article, Blundell and Hine argued for abandoning
the NCD label for many of the reasons noted before,
including that it has become a catch-all and conse-
quently meaningless label for a wide variety of con-
ditions, that there is a link between infections and
many NCDs, and that many of the social risk factors
for NCDs are also ‘communicated’ [49]. They argued
instead for a focus on the ‘human-made’ nature of
NCDs and attention to the social determinants of
health. Similar arguments about the communicability
of NCDs and their determinants through biosocial
contagion; the conflation of ‘infectiousness’ and
‘communicability’; the need to target the macro-
level ‘vectors of transmission’ of NCDs; and the
ways in which the framing of NCDs as ‘lifestyle’
diseases has driven epidemiologists to neglect other
research questions, have also been made by medical
anthropologists Seeberg and Meinert [34].
The NCD terminology was also a topic of discus-
sion during a recent workshop entitled, ‘Africa and
the Epidemiological Imagination.’ Issues such as
comorbidity and multimorbidity, interactions
between infectious and ‘non-communicable’ diseases,
commercial determinants of health, et cetera were
debated. Amy Moran-Thomas discussed her alterna-
tive notion of ‘paracommunicability’, and delibera-
tions generally led to the conclusion that ‘the frame
of ‘noncommunicable’ obscured more than it illumi-
nated,’ as summarized by Mika and Vaughan [50,51].
Moreover, it was noted that, more than just being an
issue of semantics, the framing and redefining of
NCDs in terms of so-called ‘modifiable’ behavioural
risk factors has shaped what and how epidemiological
data on these conditions are collected and conse-
quently how interventions to prevent them are
approached [51].
In the case of Malawi, for example, Vaughan
describes how the framing of NCDs there became dri-
ven by a reductive, risk factor approach that focused on
‘metabolic syndrome’ or ‘metabolic disorder’ [51]. This
emphasized individual behaviour and ‘lifestyle’ and
overlooked other complexities of metabolism including
historical processes, life-course effects of early-life
undernutrition and poverty, and the role of infection.
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Rather, Vaughan argues that the WHO framing of
NCDs as inherently ‘non-communicable’ and driven
by four modifiable risk factors led to the collection of
epidemiological data on NCDs in Malawi based on the
STEP-Wise Approach to Disease Risk Surveillance
(STEPS) survey, a standardised WHO survey that has
been implemented in many countries. The STEPS sur-
vey consists of a questionnaire collecting socio-
demographic information as well as core data on
tobacco and alcohol use, fruit and vegetable consump-
tion and physical activity. In addition, blood pressure
and anthropometric measurements and biochemical
measurements of blood glucose and cholesterol are
collected. The STEPS was conducted in Malawi in
2009. Vaughan contends that this framing of NCDs
may have led to a missed opportunity to gather data
on other types of NCDs (apart from the behavioural
and metabolic conditions); on the role of infection in
NCDs, including the HIV/AIDS epidemic which
affected Malawi; on environmental exposures; as well
as on the ongoing problem of undernutrition which has
also been linked to NCDs [51].
Similarly, work by Kwan and colleagues has shown
that the cardiovascular diseases among the world’s
poor are often not due to ischemia from ‘lifestyle’
causes, but are much more diverse in nature, includ-
ing a significant proportion due to infection, as well
as congenital conditions and other factors related to
poverty and environment [52]. Heart failure registries
from Haiti and several African countries bear this out
[52]. Thus, the danger in the restrictive framing and
classification of NCDs in a way which downplays the
links to infectious, environmental, social and societal
causes, has the potential to contribute to not only
incomplete data collection but also to restrictive
healthcare interventions, further entrenching vertical
programming in health systems, for example.
Themes: complex aetiologies and
multimorbidities
One theme that seems to emerge from the debates
is that of aetiology. While terms such as ‘infectious
diseases’ point directly toward a step in the aetio-
logical pathway of these conditions (namely infec-
tions), NCDs are defined in terms of what they are
not, as highlighted by Allen and Feigl [44]. Part of
the complication is that they are a diverse group
encompassing not only the ‘big four’ conditions,
but also mental illnesses (which were recently
added to the WHO NCD framework [36]), genetic
and congenital disorders, autoimmune disorders
and musculoskeletal conditions, among others
[46,53]. Moreover, many NCDs have very complex
aetiologies [4], including gene-environment inter-
actions and epigenetic changes. Most can be linked
to exposure to either infectious agents (human
papillomavirus, strep, hepatitis C), environmental
toxins and chemicals (air pollution, tobacco
smoke, asbestos, alcohol), injury (physical injury,
radiation) or psychosocial exposures (stress), all of
which can lead to chronic inflammatory processes,
thereby causing disease [54]. The aetiological peri-
ods are often lengthy, with many NCDs developing
over the life-course or having intergenerational
influences, as work on the fetal and developmental
origins of disease has shown [55]. Even what are
considered the modifiable metabolic risk factors
can be precipitated by various factors including
infections and undernutrition.
In addition, the traditional NCD distinction and
epidemiological transition narrative separating
NCDs from infectious diseases across time and
place seem to gloss over multimorbidities on both
an individual and a societal level. Far from belong-
ing to separate eras, communicable, maternal, neo-
natal and nutritional diseases often co-occur with
NCDs, particularly in LMICs, thereby violating the
assumptions of a separate ‘age of pestilence and
famine’ and ‘age of degenerative and man-made
disease,’ as described by the theory of epidemiolo-
gic transition [4,30,31]. This co-occurrence is com-
monly referred to as the ‘double burden of disease’
[29]. Some have even referred to a ‘triple burden of
disease’, adding the ailments of globalization, such
as pandemics and climate change, into the mix
[56]. Further, not only do NCDs and communic-
able, maternal, neonatal and nutritional diseases
often present and co-exist within the same society,
but they often co-exist within the same individual.
Interest in this area has rightfully been growing,
and the Global Alliance for Chronic Disease
recently put out a research statement highlighting
the need to consider multimorbidity in research
and healthcare [57].
Themes: socio-political determinants of
health in historical perspective
One of the other main issues that the debates around
the framing and naming of NCDs have highlighted is
a dissatisfaction with the individualistic biomedical
model of disease to the neglect of social, behavioural,
political and environmental factors [47,49,58]. These
factors include socioeconomic conditions, inequality,
food systems and industries, policies and governance,
rights, living and working conditions, et cetera [6].
Allen and Feigl argued that addressing these social
drivers when it comes to NCDs is a good starting
point that could lead to upstream thinking in other
areas [58]. Nevertheless, upstream thinking in epide-
miology and health is not necessarily novel. Since the
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mid- to late-1900s, the field of social epidemiology
has tried to draw attention to these upstream social
and societal (including political and commercial) dri-
vers of health – the ‘causes of the causes’ [6]. Often
drawing on social-ecological models, social epide-
miology attempts to examine the multiple levels at
which health is shaped, from the individual to the
macro-level. From this perspective, all disease has
social causes or implications. However, even before
the birth of this field of public health, the history of
epidemiological inquiry had an upstream focus.
Louis-Rene Villermé, Rudolf Virchow, Friedrich
Engels and others examined morbidity and mortality
among the urban and industrial poor in Europe in
the 1800s [4,6]. They related ill health to issues of
class, political economy, industrialisation, and the
social and environmental conditions in which many
people were forced to live and work. Disease was
therefore societally-produced and the work of these
scholars was the foundation of and precursor to what
Krieger considers the socio-political theories of dis-
ease distribution [6].
Similarly, Richard Horton in a recent commentary
reminded the global health community of its socio-
political origins [59]. He argued that global health is
concerned with the national and transnational
forces – including poverty, exploitation, violence,
power, and oppression – that harm health, and that
it was decolonization that birthed the global health
movement. In particular, Horton credits post-
colonial writer-clinician, Frantz Fanon with writing
the first works of the global health movement linking
colonization and medicine.
Thus, while public health may have been seen as
more of a political science in the 19th century, global
health and epidemiology seem to have lost track of
their roots in socio-political determinants of health
with the advent of biomedical and lifestyle models of
health in the 20th century [6,7]. This has led to the
individualistic and disease-based ‘black box’ epide-
miological approaches that have dominated in past
century with regard to NCDs and other conditions
[4]. Despite a resurgence in attention to social deter-
minants of health in recent decades, as exemplified by
the work of Michael Marmot and others, many would
agree that additional work is needed to expand non-
biomedical perspectives in the NCD narrative.
Where to go from here …
Naming
We acknowledge that given how embedded the NCD
terminology has become in global health and that the
public has also begun to familiarise itself with this
term, it may be unproductive at this point to argue
for a new name. Although we applaud some of the
previous efforts, it seems a strong alternative has not
yet emerged. However, the framing and frameworks
used to address NCDs need reconfiguration. Already,
as we have shown above, there are numerous
attempts to reframe the NCD narrative, and we feel
that additional work in this area would be beneficial
to disease prevention and control. Moreover, without
first addressing our underlying frameworks for
NCDs, any new names adopted may also run the
risk of assuming the same meanings and uses that
the phrase ‘NCDs’ currently has. Thus, we agree with
Herrick’s assertion in her recently published think
piece that the failure of NCDs to galvanise action is
not just due to the name but also to deeper
issues [60].
Framing and frameworks
We believe that there are a number of frameworks that
may help to better address and frame NCDs. One is
Krieger’s ecosocial theory. Ecosocial theory incorpo-
rates political economy, life-course and historical fac-
tors, accountability for social disparities in health and
for research on these inequalities, and social and bio-
logical processes at different levels and spatiotemporal
scales. It uses the concept of ‘embodiment’ to explain
how we biologically incorporate the material and social
worlds we inhabit [6] (see Figure 2).
The concept of multimorbidity introduced earlier
may also help to strengthen our response to disease by
allowing us to consider the co-occurrence of and inter-
actions between multiple conditions within individuals,
including interactions between diseases normally placed
in different categories. On a population level, a related
concept that has been gaining increasing attention is
that of ‘syndemics’. Syndemic theory posits that multi-
ple epidemics, conditions and social problems can arise
in populations due to social conditions and can interact
synergistically within these populations, creating an
excess burden of disease that is greater than the sum
Figure 2. A heuristic diagram for guiding ecosocial analyses
of disease distribution, population health, and health inequi-
ties, reproduced from Krieger [161, p. 224] with permission
from the American Public Health Association.
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of the conditions individually. These conditions are
socially-patterned, tending to cluster in populations
that are impoverished or marginalized. Rather than
viewing diseases or epidemics as discrete conditions,
syndemic theory views them in relation to and mutually
reinforcing social and environmental conditions
[34,62,63]. For example, a report was recently published
in The Lancet on the global syndemic of obesity, under-
nutrition and climate change [64]. The commissioners
put forward recommendations to address the epidemics
of obesity, undernutrition and climate change, which
they argued share common societal causes and co-occur
and interact in place and time, affecting people world-
wide in a global syndemic.
We believe that these concepts of multimorbidity and
syndemics and the use of an ecosocial frameworkmay be
particularly useful starting points for the health profes-
sions to start reframing the ways in which we think about
and act on disease prevention and control. Ideally, data
collection and interventions for NCDs would attempt to
follow an ecosocial framework and consider multimor-
bidity and syndemics by including not only chronic con-
ditions, health behaviours, and individual and household
socioeconomic status, but also infectious illnesses and
other comorbidities, undernutrition, genetic and biologi-
cal factors, psychosocial factors, and neighbourhood and
environmental characteristics. In addition, these data and
interventions would incorporate life-course perspectives
from childhood to adulthood, as well as intergeneration-
ally. Geographical information at multiple scales would
be considered, allowing one to link contextual factors to
individuals by time and place. This also means that
resources should be devoted to measuring and monitor-
ing various structural and contextual factors such as
polices that may impact well-being. However, although
this type of data collection and intervention design may
be ideal, it often turns out to be less straightforward in
practice. Limitations arise, including optimizing survey/
interview length to collect rich data without increasing
non-response; research fatigue in communities that are
often studied or under surveillance; respondent privacy
in evermore detailed data; and limited financial resources
for extensive and large-scale data collection and interven-
tions over the long-term. How to tackle these challenges
in innovative ways that will allow us to effectively study
epidemiology and respond accordingly should be
a priority for global health.
One final recommendation to consider comes from
Abel andMcQueen who argue for a social-science-based
theory of NCD causation that is driven from the social
rather than from the biomedical [38]. Going beyond
social epidemiological methods that nonetheless start
from and centre on disease outcomes, they contend
that social context should be the primary concern and
target of interventions. In other words, they argue that
even social epidemiology starts by identifying diseases
and conditions (cancer, violence, etc.) and then attempts
to understand what social factors determine those con-
ditions and which can be changed. Abel and McQueen
recommend starting first from the social context (per-
haps neighbourhoods, policy environments, etc.) and
making those, rather than the disease outcomes, the
primary factors of interest and targets of action. The
public health field has begun to move in those directions
(again), with programmes, courses and centres focused
on issues such as neighbourhoods and health, urban
health, the built environment, health and happiness,
social policy or health and society emerging at various
institutions. Nevertheless, additional movement in this
directionmay be a welcome improvement to the study of
health and illness.
McQueen and Abel further contend that, rather than
being data-driven, the approach to NCDs should be
social science based, incorporating notions of complexity
and dynamic associations, while integrating epidemiolo-
gical knowledge [38]. McQueen also argues that the
subfield of health promotion within public health is
one that could help to improve work in NCDs by addres-
sing the broad issues of social context that anthropolo-
gists and political and social scientists often focus on [41].
Health promotion, he argues, emphasizes social action,
equity, social justice, and health and human rights in
order to promote health and not merely to prevent dis-
ease. It should be noted that health promotion as a field is
not without criticism [65,66], and as McQueen acknowl-
edges, also needs more theoretical exposition [41].
Nevertheless, there may be lessons to be learned from
health promotion in the battle against NCDs.
Conclusions
When it comes to naming and classifying NCDs, the
optimal solution may still be up for debate.
However, it does seem clear that the current framing
is inadequate. Moreover, the debates discussed in
this paper highlight themes that are not unique to
NCDs but touch on how we think about disease and
illness more generally. The debates on NCDs reveal
a desire for solutions that give renewed attention to
the socio-structural, political and environmental
determinants of health and for the incorporation of
interdisciplinary perspectives, including those ema-
nating from the social sciences. In summary, we
believe that it is critical to question the ways in
which we frame and name NCDs and be critically
aware of the assumptions that underlie our typolo-
gical systems. Doing so may improve the epidemio-
logical data we collect, the methods we use, the
resources we summon, and the interventions we
propose to combat this health issue. The concepts
of multimorbidity and syndemics, frameworks such
as ecosocial theory, and social-science-based
approaches may provide promising avenues for
reframing NCDs.
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Paper context
Health professionals and scholars from various fields have
expressed dissatisfaction with the framing and terminology of
non-communicable diseases (NCDs). This paper synthesizes
these debates, analysing themes that emerge. The implications
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